# Cetuximab in Combination With Chemotherapy for Patients With Head and Neck Cancer

> **NCT01020864** · PHASE2 · WITHDRAWN · sponsor: **Per Pfeiffer**

## Conditions studied

- Head and Neck Neoplasms

## Interventions

- **DRUG:** Cetuximab
- **DRUG:** Carboplatin
- **DRUG:** Vinorelbine

## Key facts

- **NCT ID:** NCT01020864
- **Lead sponsor:** Per Pfeiffer
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2010-01
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2020-11-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01020864

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01020864, "Cetuximab in Combination With Chemotherapy for Patients With Head and Neck Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01020864. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*